Adtalem Global Education

Adtalem reported Q2 2026 revenue of $503.4 million (up 12.4%) and adjusted earnings per share of $2.43 (expected $2.19). The adjusted EBITDA margin rose 290 basis points to 30.8% and student enrollment increased 6.3% to 97,010. The company raised its full-year guidance, completed a $150 million share buyback program and reports a solid balance sheet with net leverage of 0.9x. » More on de.investing.com

California-based Global IMC sold all 50,933 shares of Adtalem Global Education in Q3, a position worth about $6.48 million at quarter-average prices, according to an SEC filing. The exit reduced a holding that had been 1.7% of the fund’s assets and comes after Adtalem's stock surged nearly 70% earlier in the year before retreating. Adtalem recently reported revenue growth, higher adjusted EPS and enrollment gains, but shares fell on concerns about softer-than-expected growth. » More on finance.yahoo.com

Adtalem reported a 10.8% revenue increase in Q1 2026 to $462.3 million and adjusted earnings per share of $1.75 (+35.7%), beating analyst estimates. Total student enrollments rose 8.0% to 97,359, driven mainly by strong growth at Walden University, while Chamberlain saw margin setbacks. Adjusted EBITDA grew to $112.0 million, the adjusted EBITDA margin improved by 100 basis points, and trailing-12-month free cash flow was $319 million. Adtalem reaffirmed its full-year guidance of $1,900–$1,940 million in revenue and adjusted EPS of $7.60–$7.90; the company is relying on further enrollment growth, buybacks, and targeted healthcare partnerships. » More on de.investing.com